• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

BIRC5 促进喉鳞状细胞癌的进展并预测其预后。

BIRC5 promotes cancer progression and predicts prognosis in laryngeal squamous cell carcinoma.

机构信息

Guangdong Provincial Key Laboratory of Conservation and Precision Utilization of Characteristic Agricultural Resources in Mountains Areas, School of Life Science of Jiaying University, Meizhou, China.

Henry-Fork School of Food Sciences, Shaoguan University, Shaoguan, China.

出版信息

PeerJ. 2022 Feb 1;10:e12871. doi: 10.7717/peerj.12871. eCollection 2022.

DOI:10.7717/peerj.12871
PMID:35178302
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8815368/
Abstract

BACKGROUND

Laryngeal squamous cell carcinoma (LSCC) remains one of the most common respiratory tumors worldwide. Baculoviral inhibitor of apoptosis repeat containing 5 ( is a member of the inhibitor-of-apoptosis protein family. BIRC5 plays an important role in various types of cell proliferation, differentiation, migration and invasion. However, the specific role of BIRC5 in LSCC remains unclear.

METHODS

To provide a prognostic biomarker for LSCC, we screened the prognostic genes of LSCC bioinformatics. PPI network and KEGG pathways were used to select hub genes. Clinical prognoses were performed using a Kaplan-Meier plotter and Cox proportional-hazard analysis. BIRC5 expression in LSCC tissues and cell lines were detected by RT-PCR, Western blot and Immunohistochemistry (IHC). Cell proliferation, cell cycle and cell apoptosis were detected with Cell Counting Kit-8 (CCK-8) and Flow Cytometry assay, respectively.

RESULTS

Here, was strongly correlated with higher tumor grade and differentiation. BIRC5 was highly expressed in LSCC tissues when compared with normal tissues and increased expression of BIRC5 was associated with overall survival in LSCC patients. The suppression of BIRC5 induced cell apoptosis and cell cycle arrest, thereby inhibiting the proliferation of LSCC cells. The survival analysis confirmed that higher level of BIRC5 expression predicted poor prognosis of LSCC patients. BIRC5 may act as an oncogene of LSCC development and was suggested as a promising prognostic biomarker for LSCC.

摘要

背景

喉鳞状细胞癌(LSCC)仍然是世界上最常见的呼吸道肿瘤之一。杆状病毒凋亡抑制蛋白重复包含 5(BIRC5)是凋亡抑制蛋白家族的一员。BIRC5 在各种类型的细胞增殖、分化、迁移和侵袭中发挥重要作用。然而,BIRC5 在 LSCC 中的具体作用尚不清楚。

方法

为了提供 LSCC 的预后生物标志物,我们对 LSCC 的生物信息学进行了预后基因筛选。使用蛋白质-蛋白质相互作用(PPI)网络和京都基因与基因组百科全书(KEGG)途径选择关键基因。使用 Kaplan-Meier 绘图仪和 Cox 比例风险分析进行临床预后分析。通过 RT-PCR、Western blot 和免疫组织化学(IHC)检测 LSCC 组织和细胞系中的 BIRC5 表达。使用细胞计数试剂盒-8(CCK-8)和流式细胞术分别检测细胞增殖、细胞周期和细胞凋亡。

结果

在这里,与高肿瘤分级和分化相关。与正常组织相比,LSCC 组织中 BIRC5 表达水平较高,BIRC5 表达水平升高与 LSCC 患者的总生存率相关。BIRC5 的抑制诱导细胞凋亡和细胞周期停滞,从而抑制 LSCC 细胞的增殖。生存分析证实,BIRC5 表达水平较高预示着 LSCC 患者预后不良。BIRC5 可能作为 LSCC 发展的癌基因,并被认为是 LSCC 的有前途的预后生物标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5871/8815368/29d0bf7f0946/peerj-10-12871-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5871/8815368/75f1bc168e20/peerj-10-12871-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5871/8815368/fe93b839ea53/peerj-10-12871-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5871/8815368/f099322dd2ba/peerj-10-12871-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5871/8815368/81487f281a7a/peerj-10-12871-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5871/8815368/f86da192a528/peerj-10-12871-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5871/8815368/4fdd3d73c0ec/peerj-10-12871-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5871/8815368/29d0bf7f0946/peerj-10-12871-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5871/8815368/75f1bc168e20/peerj-10-12871-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5871/8815368/fe93b839ea53/peerj-10-12871-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5871/8815368/f099322dd2ba/peerj-10-12871-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5871/8815368/81487f281a7a/peerj-10-12871-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5871/8815368/f86da192a528/peerj-10-12871-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5871/8815368/4fdd3d73c0ec/peerj-10-12871-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5871/8815368/29d0bf7f0946/peerj-10-12871-g007.jpg

相似文献

1
BIRC5 promotes cancer progression and predicts prognosis in laryngeal squamous cell carcinoma.BIRC5 促进喉鳞状细胞癌的进展并预测其预后。
PeerJ. 2022 Feb 1;10:e12871. doi: 10.7717/peerj.12871. eCollection 2022.
2
SLC7A11, a component of cysteine/glutamate transporter, is a novel biomarker for the diagnosis and prognosis in laryngeal squamous cell carcinoma.SLC7A11,半胱氨酸/谷氨酸转运体的一个组成部分,是喉鳞状细胞癌诊断和预后的一个新的生物标志物。
Oncol Rep. 2017 Nov;38(5):3019-3029. doi: 10.3892/or.2017.5976. Epub 2017 Sep 20.
3
The Novel Circular RNA circTRIO Silence Inhibits the Progression of Laryngeal Squamous Cell Carcinoma.环状 RNA circTRIO 通过沉默抑制喉鳞状细胞癌的进展。
DNA Cell Biol. 2023 Jul;42(7):421-432. doi: 10.1089/dna.2023.0043. Epub 2023 May 22.
4
Tumor necrosis factor superfamily member 13 is a novel biomarker for diagnosis and prognosis and promotes cancer cell proliferation in laryngeal squamous cell carcinoma.肿瘤坏死因子超家族成员13是一种用于诊断和预后的新型生物标志物,并促进喉鳞状细胞癌中的癌细胞增殖。
Tumour Biol. 2016 Feb;37(2):2635-45. doi: 10.1007/s13277-015-4016-8. Epub 2015 Sep 23.
5
Integrative Analysis Reveals STC2 as a Prognostic Biomarker of Laryngeal Squamous Cell Carcinoma.整合分析揭示 STC2 是喉鳞状细胞癌的预后生物标志物。
Appl Biochem Biotechnol. 2024 Jul;196(7):3891-3913. doi: 10.1007/s12010-023-04727-z. Epub 2023 Oct 4.
6
Triosephosphate isomerase 1 may be a risk predictor in laryngeal squamous cell carcinoma: a multi-centered study integrating bulk RNA, single-cell RNA, and protein immunohistochemistry.磷酸丙糖异构酶 1 可能是喉鳞状细胞癌的风险预测因子:一项整合了 bulk RNA、单细胞 RNA 和蛋白免疫组化的多中心研究。
Eur J Med Res. 2023 Dec 15;28(1):591. doi: 10.1186/s40001-023-01568-8.
7
HOXB9 promotes laryngeal squamous cell carcinoma progression by upregulating MMP12.HOXB9 通过上调 MMP12 促进喉鳞状细胞癌的进展。
Funct Integr Genomics. 2024 Apr 18;24(3):78. doi: 10.1007/s10142-024-01357-4.
8
Downregulation of miR-29c-3p is associated with a poor prognosis in patients with laryngeal squamous cell carcinoma.miR-29c-3p 的下调与喉鳞状细胞癌患者的不良预后相关。
Diagn Pathol. 2019 Oct 15;14(1):109. doi: 10.1186/s13000-019-0893-2.
9
Zinc finger protein x-linked (ZFX) contributes to patient prognosis, cell proliferation and apoptosis in human laryngeal squamous cell carcinoma.X连锁锌指蛋白(ZFX)对人喉鳞状细胞癌患者的预后、细胞增殖和凋亡有影响。
Int J Clin Exp Pathol. 2015 Nov 1;8(11):13886-99. eCollection 2015.
10
Increased expression of lncRNA FTH1P3 predicts a poor prognosis and promotes aggressive phenotypes of laryngeal squamous cell carcinoma.lncRNA FTH1P3表达增加预示喉鳞状细胞癌预后不良并促进其侵袭性表型。
Biosci Rep. 2019 Jun 18;39(6). doi: 10.1042/BSR20181644. Print 2019 Jun 28.

引用本文的文献

1
Machine learning-driven identification of exosome- related biomarkers in head and neck squamous cell carcinoma.机器学习驱动的头颈部鳞状细胞癌中外泌体相关生物标志物的识别
Front Immunol. 2025 May 22;16:1590331. doi: 10.3389/fimmu.2025.1590331. eCollection 2025.
2
Exploring BIRC family genes as prognostic biomarkers and therapeutic targets in prostate cancer.探索BIRC家族基因作为前列腺癌的预后生物标志物和治疗靶点。
Discov Oncol. 2025 Feb 26;16(1):240. doi: 10.1007/s12672-025-02002-7.
3
BIRC5 Is a Potential Biomarker Associated with Immune System Infiltration in Glioma.

本文引用的文献

1
Identification of miR-145-5p-Centered Competing Endogenous RNA Network in Laryngeal Squamous Cell Carcinoma.喉鳞状细胞癌中 miR-145-5p 为中心的竞争性内源性 RNA 网络的鉴定。
Proteomics. 2019 Nov;19(21-22):e1900020. doi: 10.1002/pmic.201900020. Epub 2019 Jun 20.
2
Identification of Potential Crucial Genes Associated With the Pathogenesis and Prognosis of Endometrial Cancer.与子宫内膜癌发病机制和预后相关的潜在关键基因的鉴定
Front Genet. 2019 Apr 26;10:373. doi: 10.3389/fgene.2019.00373. eCollection 2019.
3
Prognostic Value of BIRC5 in Lung Adenocarcinoma Lacking EGFR, KRAS, and ALK Mutations by Integrated Bioinformatics Analysis.
BIRC5是一种与胶质瘤免疫系统浸润相关的潜在生物标志物。
J Korean Neurosurg Soc. 2025 Mar;68(2):184-201. doi: 10.3340/jkns.2024.0106. Epub 2025 Feb 26.
4
Suppressed oncogenic molecules involved in the treatment of colorectal cancer by fecal microbiota transplantation.粪便微生物群移植治疗结直肠癌中涉及的被抑制的致癌分子。
Front Microbiol. 2024 Nov 13;15:1451303. doi: 10.3389/fmicb.2024.1451303. eCollection 2024.
5
Construction of a novel tumor mutation burden-related mRNA signature for prognosis prediction in laryngeal squamous cell carcinoma.构建一种新型与肿瘤突变负荷相关的 mRNA 标志物用于预测喉鳞状细胞癌的预后。
Medicine (Baltimore). 2024 Nov 1;103(44):e40431. doi: 10.1097/MD.0000000000040431.
6
Exploring the prognostic implications of cuproptosis-associated alterations in clear cell renal cell carcinoma via in vitro experiments.通过体外实验探索铜死亡相关改变对透明细胞肾细胞癌预后意义。
Sci Rep. 2024 Jul 23;14(1):16935. doi: 10.1038/s41598-024-67756-6.
7
FAM83D acts as an oncogene by regulating cell cycle progression via multiple pathways in synovial sarcoma: a potential novel downstream target oncogene of anlotinib.FAM83D通过多种途径调节滑膜肉瘤的细胞周期进程,发挥癌基因作用:一种潜在的安罗替尼下游新型靶标癌基因。
Discov Oncol. 2024 Mar 21;15(1):82. doi: 10.1007/s12672-024-00943-z.
8
Protein expression analysis for predicting recurrent laryngeal squamous cell carcinoma.用于预测复发性喉鳞状细胞癌的蛋白质表达分析
Biomed Rep. 2023 Dec 1;20(1):15. doi: 10.3892/br.2023.1702. eCollection 2024 Jan.
9
CRM1 expression: association with high prognostic value in laryngeal cancer.CRM1 表达:与喉癌高预后价值相关。
Turk J Med Sci. 2023 Aug;53(4):909-923. doi: 10.55730/1300-0144.5655. Epub 2023 Aug 18.
10
BIRC5 Inhibition Is Associated with Pyroptotic Cell Death via Caspase3-GSDME Pathway in Lung Adenocarcinoma Cells.BIRC5 抑制通过 Caspase3-GSDME 通路与肺腺癌细胞中的细胞焦亡死亡相关。
Int J Mol Sci. 2023 Sep 28;24(19):14663. doi: 10.3390/ijms241914663.
基于综合生物信息学分析的 EGFR、KRAS 和 ALK 突变缺失型肺腺癌中 BIRC5 的预后价值。
Dis Markers. 2019 Apr 9;2019:5451290. doi: 10.1155/2019/5451290. eCollection 2019.
4
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.全球癌症统计数据 2018:GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.
5
Lentiviral CRISPR/Cas9 nickase vector mediated BIRC5 editing inhibits epithelial to mesenchymal transition in ovarian cancer cells.慢病毒CRISPR/Cas9切口酶载体介导的BIRC5编辑抑制卵巢癌细胞的上皮-间质转化
Oncotarget. 2017 Oct 17;8(55):94666-94680. doi: 10.18632/oncotarget.21863. eCollection 2017 Nov 7.
6
UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses.UALCAN:一个促进肿瘤亚组基因表达和生存分析的平台。
Neoplasia. 2017 Aug;19(8):649-658. doi: 10.1016/j.neo.2017.05.002. Epub 2017 Jul 18.
7
BIRC5 (survivin): a pejorative prognostic marker in stage II/III breast cancer with no response to neoadjuvant chemotherapy.BIRC5(存活素):II/III期乳腺癌中对新辅助化疗无反应的不良预后标志物。
Breast Cancer Res Treat. 2016 Oct;159(3):499-511. doi: 10.1007/s10549-016-3961-2. Epub 2016 Sep 3.
8
Gene expression analysis of laryngeal squamous cell carcinoma.喉鳞状细胞癌的基因表达分析
Genom Data. 2015 May 8;5:9-12. doi: 10.1016/j.gdata.2015.04.024. eCollection 2015 Sep.
9
Global cancer statistics, 2012.全球癌症统计数据,2012 年。
CA Cancer J Clin. 2015 Mar;65(2):87-108. doi: 10.3322/caac.21262. Epub 2015 Feb 4.
10
STRING v10: protein-protein interaction networks, integrated over the tree of life.STRING v10:整合了整个生命之树的蛋白质-蛋白质相互作用网络。
Nucleic Acids Res. 2015 Jan;43(Database issue):D447-52. doi: 10.1093/nar/gku1003. Epub 2014 Oct 28.